MyChesCo on MSN2d
ChromaTan and Landmark Bio Receive NIIMBL Grant to Advance AAV Gene Therapy ManufacturingChromaTan Inc. and Landmark Bio PBLLC have been awarded a grant from the National Institute for Innovation in Manufacturing ...
OXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' category Oxford, UK – 21 March 2025: OXB (LSE: OXB) (the ...
Scientists developed a promising gene replacement therapy for Dravet syndrome in mice. The therapy alleviated symptoms ...
As other gene editing programs fold or get sold, Arbor Biotechnologies has secured $73.9 million to advance its lead ...
In a groundbreaking advancement for families grappling with the challenges of Dravet syndrome, a rare and life-altering form ...
In a groundbreaking advancement for families grappling with the challenges of Dravet syndrome, a rare and life-altering form ...
Bharat Biotech has launched India's first vertically integrated cell and gene therapy facility in Telangana, investing USD 75 ...
Asian News International on MSN18h
Bharat Biotech launches India's only integrated cell, gene therapy, and viral production facilityBharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and manufacturing, ...
Bharat Biotech aims to democratize gene therapies, traditionally considered prohibitively expensive and available primarily ...
X-linked severe combined immunodeficiency disease (X-SCID) is a rare genetic disorder characterized by profound defects in ...
One patient with Duchenne muscular dystrophy (DMD) has passed away following treatment with Sarepta Therapeutics’ gene therapy Elevidys, the biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback